GB006, Inc. operates as a biopharmaceutical company. The company is headquartered in San Diego, CA.

Stealth BioTherapeutics, Inc., part of Stealth BioTherapeutics Corp., is a company headquartered in Newton, MA, that develops therapies to treat the mitochondrial dysfunctions and age-related diseases. The firm was founded in 2007. Irene P. McCarthy is the current CEO, occupying that position since 2009.\nThe company says this about itself: The Company is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction. Mitochondria, found in nearly every cell in the body, are the body's main source of energy production and are critical for normal organ function. Dysfunctional mitochondria characterize a number of rare genetic diseases and are involved in many common age-related diseases, typically involving organ systems with high energy demands such as the eye, the neuromuscular system, the heart and the brain. The Company believes that its lead product candidate, elamipretide, has the potential to treat ophthalmic diseases, such as dry AMD, rare neuromuscular disorders, such as primary mitochondrial myopathy, and rare cardiomyopathies, such as Barth syndrome. The Company has a deep pipeline of novel mitochondria-targeted compounds under evaluation as therapeutic product candidates.

Adhaere Pharmaceuticals is a provider and developer of novel therapeutics in Skokie.

The Georgia Tech Research Corp. provides research and technology support services. Its services include accounting and reports, researcher and operational support services. The comapny was founded by Preston S. Arkwright, Fuller E. Callaway, Jr. and Monie A. Ferst on April 13, 1937 and is headquartered in Atlanta, GA.

Zhejiang Chengxin Pharmaceutical Co., Ltd., established on 2001-06-22, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Drug retail;Drug import and export;Health food production;food production;food sales;Food Internet Sales;Production of medical masks;Production of Class II Medical Devices;Production of protective equipment for medical personnel(Class II medical device)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Import and export;Technology Import and Export;Healthy food(prepackaged)Sales;food sales(Only sell prepackaged food);Food Internet Sales(Only sell prepackaged food);Wholesale medical masks;Medical Mask Retail;Wholesale of protective equipment for medical staff;Retailing of protective equipment for healthcare workers;daily mask(non-medical)Production;daily mask(non-medical)Sales;Sales of labor protection products;Production of labor protection products;Manufacture of technical textile products;Sales of industrial textile products(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Guangzhou Zhongyi Pharmaceutical Co., Ltd. is a pharmaceutical company in China. It offers chinese medicines in forms of tablets, capsules, creams & liquid. The company is headquartered in Guangzhou, CN.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Otsuka Pharmaceutical Factory, Inc. manufactures and distributes pharmaceutical and nutritional products. Its products include medical foods, hine E-gel, processlead, engelead, innerpower, oronine h ointment, urepearl plus lotion 10 and urepearl plus cream. The company was founded on September 1, 1921 and is headquartered in Naruto, Japan.

National Center of Neurology and Psychiatry provides treatment and prevention therapy for mental, nervous, and developmental disorders.

Radikal Therapeutics, Inc. develops transformative pharmaceuticals of bifunctional edox-based small molecules. The company was founded by Andrew L. Salzman and is headquartered in West Tisbury, MA.

Japan Tobacco, Inc. engages in the manufacture and sale of tobacco, pharmaceutical and processed food products. It operates through the following divisions: Japanese Domestic Tobacco, International Tobacco, Pharmaceutical, and Processed Food. The Japanese Domestic segment deals with the production and sale of tobacco products in domestic areas. The International Tobacco segment manufactures and markets tobacco products worldwide. The Pharmaceutical segment develops, manufactures, and sells prescription drugs. The Processed Food segment offers processed food, bakery products and seasonings. The company was founded on April 1, 1985 and is headquartered in Tokyo, Japan.

Interleukin Genetics, Inc. is a genetics-focused personalized health company that develops genetic tests for sale to the emerging personalized health market. Their vision is to build a leading personalized health and wellness company. They believe that the science of applied genetics can empower individuals to personalize their health and provide valuable information to assist in drug development. They currently have two primary focus areas to their business. The first is personalized health, which is primarily focused on providing genetic test products to customers. These products are distributed via sales partners and their own sales channels, with the goal of providing guidance for the individual interested in improving their health and wellness. The second is a research and development effort focused on developing genetic tests linked to a partner’s products for marketing and sales into medical and dental channels. Both areas contribute toward their overall mission of providing products that can help individuals improve and maintain their health through preventive measures.

Shandong Fangming Pharmaceutical Stock Co. Ltd. is a private company headquartered in Shandong, China, with operations in China. The firm manufactures and supplies pharmaceutical products.

Zhejiang Jutai Pharmaceutical Co., Ltd., established on 1997-03-19, The scope of business includes powder,tablet(Contains anti-tumor),hard capsule,Granule production;The business place of the branch is located at Donggang 1st Road, Kecheng District, Quzhou City51No. Engaged in hard capsules(Penicillins,Cephalosporins),tablet(Penicillins,Cephalosporins),Granules(Penicillins,Cephalosporins),dry suspension(Penicillins,Cephalosporins),powder injection(Cephalosporins)Production(With valid<Pharmaceutical Production License>operate);Electrical Equipment(car not included),metallic material,building materials,Sales of packaging materials;Import and export;Medical Technology Development,technology transfer,Technical Services.

Ischemix, Inc., a pharmaceutical company, develops small molecule drugs for the treatment and prevention of ischemia-reperfusion injury. Its product includes CMX-2043, a cardio-protective drug that combines Akt pathway-mediated cell survival effects and anti-oxidant activity in a single small molecule, as well as is used for the prevention of peri-operative ischemia-reperfusion injury in patients undergoing elective percutaneous coronary intervention procedures. The company’s drugs also protect against the damaging effects associated with ischemia in brain and other organs. Ischemix, Inc. was formerly known as CereMedix, Inc. and changed its name to Ischemix, Inc. in February 2006. The company was founded in 1999 and is headquartered in Maynard, Massachusetts.